NASDAQ: CYCC
Cyclacel Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their CYCC stock forecasts and price targets.

Forecast return on equity

Is CYCC forecast to generate an efficient return?

Company
63,892.97%
Industry
140.86%
Market
89.98%
CYCC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CYCC forecast to generate an efficient return on assets?

Company
52,394.29%
Industry
32.43%
CYCC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CYCC revenue growth forecast

How is CYCC forecast to perform vs Biotechnology companies and vs the US market?

Company
1,586.6%
Industry
56.37%
Market
9.57%
CYCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CYCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CYCC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CYCC$0.41N/AN/A
KPRX$3.02$10.00+231.13%Buy
EVGN$1.38$3.50+153.62%Strong Buy
MBRX$0.64$5.33+730.69%Strong Buy
CAPS$1.79N/AN/A

Cyclacel Pharmaceuticals Stock Forecast FAQ

What is CYCC's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CYCC) forecast ROE is 63,892.97%, which is considered strong.

If you're new to stock investing, here's how to buy Cyclacel Pharmaceuticals stock.

What is CYCC's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CYCC) forecast ROA is 52,394.29%, which is higher than the forecast US Biotechnology industry average of 32.43%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.